COPAXONE sol inj 40 mg/ml ser pré 12 x 1 ml
7680563630031
CH-56363
L03AX13
01.99.0.
Reimbursement limitations:
COPAXONE
Au maximum 3 fois 40 mg par semaine.
1 / 3
google
Details
- Product number
- 5636303
- CPT
- -
- Packaging group
- 12
- Unit
- Fertigspritze(n)
- Composition
- glatirameri acetas 40 mg corresp. glatiramerum 36 mg, mannitolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Copaxone 40mg/ml, Injektionslösung in einer Fertigspritze
Injektionslösung
12
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | WIZUS |
|
(N/A)
|
36.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 805.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2017
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 56363
- Drug name
- Copaxone, Injektionslösung in einer Fertigspritze
- Galenic form
- LSPA
- ATC Code
- L03AX13
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/01/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- COPAXONE sol inj 40 mg/ml ser pré 12 x 1 ml
- Description (DE)
- COPAXONE Inj Lös 40 mg/ml Fertspr 12 x 1 ml
- Market launch
- 01/11/2016
- Narcotic (BTM)
- No